Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia

American Journal of Perinatology

Volumn 26, Issue 4, 2009, Pages 317-322

  Chock, Valerie Y ^a,e   Van Meurs, Krisa P ^a   Hintz, Susan R ^a   Ehrenkranz, Richard A ^b   Lemons, James A ^c   Kendrick, Douglas E ^d   Stevenson, David K ^a  

^a STANFORD UNIVERSITY   (United States)

^b YALE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d RTI INTERNATIONAL   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; Nitric oxide; Oligohydramnios; PPROM; Pulmonary hypoplasia

Indexed keywords

NITRIC OXIDE; PLACEBO;

ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LEUKOMALACIA; LUNG DYSPLASIA; LUNG HYPOPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN MORTALITY; OLIGOHYDRAMNIOS; OUTCOME ASSESSMENT; OXYGEN TENSION; OXYGENATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; BRONCHOPULMONARY DYSPLASIA; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; NITRIC OXIDE; OLIGOHYDRAMNIOS; PILOT PROJECTS; PREGNANCY; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 63849244790     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0028-1104743     Document Type: Article

References (21)

1. Mercer BM, Goldenberg RL, Meis PJ, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183:738-745
2. Winn HN, Chen M, Amon E, Leet TL, Shumway JB, Mostello D. Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes: a critical analysis. Am J Obstet Gynecol 2000; 182:1638-1644
3. Kilbride HW, Yeast J, Thibeault DW. Defining limits of survival: lethal pulmonary hypoplasia after midtrimester premature rupture of membranes. Am J Obstet Gynecol 1996;175:675-681
4. Kumar VH, Hutchison AA, Lakshminrusimha S, Morin FC III, Wynn RJ, Ryan RM. Characteristics of pulmonary hypertension in preterm neonates. J Perinatol 2007;27:214-219
5. Geary C, Whitsett J. Inhaled nitric oxide for oligohydramnios-induced pulmonary hypoplasia: a report of two cases and review of the literature. J Perinatol 2002;22:82-85
6. Peliowski A, Finer NN, Etches PC, Tierney AJ, Ryan CA. Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J Pediatr 1995;126:450-453
7. Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 2005;353:13-22
8. Van Meurs KP, Hintz SR, Ehrenkranz RA, et al. Inhaled nitric oxide in infants > 1500 g and < 34 weeks gestation with severe respiratory failure. J Perinatol 2007;27:347-352
9. Kabra NS, Kluckow MR, Powell J. Nitric oxide in preterm infant with pulmonary hypoplasia. Indian J Pediatr 2004;71:427-429
10. Uga N, Ishii T, Kawase Y, Arai H, Tada H. Nitric oxide inhalation therapy in very low-birthweight infants with hypoplastic lung due to oligohydramnios. Pediatr Int 2004;46:10-14
11. Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000;342:469-474
12. Hoffman GM, Nelin LD. Mean airway pressure and response to inhaled nitric oxide in neonatal and pediatric patients. Lung 2005;183:441-453
13. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405
14. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 2005;172:899-906
15. Roberts JD Jr, Chiche JD, Weimann J, Steudel W, Zapol WM, Bloch KD. Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ Res 2000;87:140-145
16. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 1997;41:457-463
17. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-919
18. Ziesche R, Petkov V, Williams J, et al. Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue. Proc Natl Acad Sci U S A 1996;93:12478-12483
19. Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006;355:354-364
20. American Academy of Pediatrics Committee on Fetus and Newborn. Use of inhaled nitric oxide. Pediatrics 2000;106: 344-345
21. Barrington KJ, Finer NN. Inhaled nitric oxide for preterm infants: a systematic review. Pediatrics 2007;120:1088-1099